Matthew Ragsdell, DO
Sports Medicine · South Pasadena, FLNPI 1629196811
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 83.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $25,066 and has fallen 99.9% since, to $14 in 2025. Among sports medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $265.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$30K
- Elite Orthopedics, LLC$3K
- Stryker$2K
- Johnson & Johnson$215
- MVP Orthopedics Inc$197
- Stability Biologics, LLC$87
- plus $444 from 14 others
What the payments were for
- Consulting fees$20,71257%
- Speaking & faculty fees$5,43815%
- Travel & lodging$3,3699%
- Food & beverage$5,10114%
- Education$1,8145%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 48 | $30,345 |
| Elite Orthopedics, LLC | 23 | $3,129 |
| Stryker | 26 | $2,018 |
| Johnson & Johnson | 12 | $215 |
| MVP Orthopedics Inc | 4 | $197 |
| Stability Biologics, LLC | 2 | $87 |
| Nextstep Arthropedix, LLC | 1 | $81 |
| Pacira Therapeutics, Inc. | 4 | $60 |
| Pfizer | 4 | $58 |
| Zimmer Biomet | 2 | $45 |
| Smith+Nephew | 1 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Novo Nordisk | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Organogenesis Inc. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$4,500
- MAKO$630
- TRIATHLON$522
- AXSOS$263
- GAMMA$134
How this compares
$36,434 in reported general payments places this provider in the 90th percentile of 402 sports medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 37 | $842 |
| Methylprednisolone | 22 | $176 |
| Methocarbamol | 12 | $123 |
| Meloxicam | 43 | $89 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $74 |
| Tramadol Hcl | 20 | $59 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in South Pasadena
- Gregory MinesSouth Pasadena$34K
- Lee KaplanMiami$11.3M
- Patrick SmithNaples$2.9M
- Ryan SimovitchWest Palm Beach$1.1M
- Bruce LevyOrlando$816K
- Gautam YagnikMiami$440K
- Carl DilellaVero Beach$384K
- Adam AnzGulf Breeze$354K
- Stanton LongeneckerJacksonville$330K
- Luga PodestaNaples$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.